A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance with Oxpentifylline (HERO) trial

Authors
Cass Alan
Hawley C.
Pascoe E.
Pedagogos E.
McDonald S.
Ferrari P.
Johnson D.
Walker R.
Reidlinger D.
Badve S.
Dalziel K.
Clarke P.
Morrish A.
Scaria A.
Vergara L.
Perkovic Vlado
Type of Publication
Journal Article
Year of Publication
2014
Journal
American Journal of Kidney Diseases
Language
Eng
ISBN Number
1523-6838 (Electronic)<br/>0272-6386 (Linking)
Volume
pii: S0272-6386(14)00987-1.